astrazeneca glp 1 drug AstraZeneca's elecoglipron just posted some of the most closely watched Phase IIb data of the year and it landed at the right conference. Results from the VISTA and SOLSTICE trials, published simultaneously AstraZeneca’s experimental obesity pill helped

Its natural mechanism provides excellent safety while delivering meaningful anti-aging and body composition benefits

Coronary Microvascular Disease Pathogenic Mechanisms and Therapeutic Options: JACC State-Of-The-Art Review

Figure 8 illustrates the fate of dietary polyphenols within the human digestive system, beginning with their natural occurrence in fruits and vegetables as aglycones, glycosides, or bound forms

mGIPR-Ab treatment reduced total plasma cholesterol in Gipr fl/fl control mice but not in Gipr Syn/ mice

Copper deficiency can occur with inadequate copper intake, but excess copper intake may cause toxicity to human